|
|
|
| GlaxoSmithKline plc: PharmaVitae Profile |
|
| Table of Contents Published: 2009/10 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for GSK in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales ... |
| Emerging Markets Series: Indonesia and Philippines |
|
| Table of Contents Published: 2009/10 Published by: Datamonitor |
| As the developed markets are becoming increasingly mature, Pharma is turning to the emerging markets, where long-term growth can be sustained. Of particular interest are Indonesia and the Philippines, which are currently going through major reforms to exp ... |
| Systemic Fungal Infection Therapeutics Market - South Korea |
|
| Table of Contents Published: 2009/10 Published by: Frost & Sullivan |
| This research service aims to provide an update on the epidemiology of systemic fungal infection, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the systemic fungal infec ... |
| Systemic Fungal Infection Therapeutics Market - Hong Kong |
|
| Table of Contents Published: 2009/10 Published by: Frost & Sullivan |
| This research service aims to provide an update on the epidemiology of systemic fungal infection, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the systemic fungal infec ... |
| Systemic Fungal Infection Therapeutics Research - Malaysia |
|
| Table of Contents Published: 2009/10 Published by: Frost & Sullivan |
| This research service aims to provide an update on the epidemiology of systemic fungal infection, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the systemic fungal infec ... |
| Transfection Life Science Dashboard Series 2 |
|
| Table of Contents Published: 2009/10 Published by: Percepta Associates Inc. |
| The ability to transfect DNA into mammalian cells and cell lines is a critical step in the analysis of gene expression, protein structure and function and molecular interactions within the cell. The Transfection Dashboard Series Two was developed from res ... |
| The Market Outlook for Research Products in FY2010 |
|
| Table of Contents Published: 2009/10 Published by: BioInformatics, LLC |
| The Market Outlook for Research Products in FY2010 compares and contrasts FY2009 (actual) and FY2010 projected) budgets - in total, and by product category with a special focus on market segment and regional differences. In this report, European and U.S. ... |
| Pharmaceutical Mergers and Acquisitions |
|
| Table of Contents Published: 2009/10 Published by: Cutting Edge Information |
| Pharmaceutical Mergers and Acquisitions guides you to build an M&A plan that focuses on key goals, avoids costly mistakes, and realizes deal potential as quickly as possible. CEI designed this study to identify the primary drivers of M&A activity. Through ... |
| Global Skin Cancer Therapeutics Markets |
|
| Table of Contents Published: 2009/10 Published by: Frost & Sullivan |
| This research service analyses the global skin cancer therapeutics market. It analyses market drivers, restraints and challenges faced by industry participants. Revenue forecasts and pipeline analysis has been discussed. It also provides strategic recomme ... |
| Biosimilars: Beyond the first product wave |
|
| Table of Contents Published: 2009/10 Published by: Espicom Business Intelligence |
| The future of the pharmaceutical industry lies with biotechnology. Biotech drugs account for around 10-15% of the current pharmaceutical market, and the sector is outperforming the market as a whole in terms of growth. ... |
| Competitor Analysis: Coagulation Factors |
|
| Table of Contents Published: 2009/10 Published by: La Merie |
| The present Competitive Intelligence Report about Coagulation Factors provides a competitor evaluation in the field of plasma-derived and recombinant coagulation factors for topical or systemic administration to treat hereditary or acquired coagulation di ... |
| South African Advanced Wound Care Market |
|
| Table of Contents Published: 2009/10 Published by: Frost & Sullivan |
| Advanced wound care in South Africa is typified by four key segments; moist wound care, antimicrobial wound care, negative pressure wound therapy, and advanced therapies. Lucrative growth was experienced in the market in 2008 particularly from the public ... |
| Malaria Patent Landscape 2009 |
|
| Table of Contents Published: 2009/10 Published by: France Innovation Scientifique et Transfert (FIST SA) |
| Malaria, along with HIV and Tuberculosis, is one of the three most common infectious diseases in the world. It has infected human beings for over 50,000 years and may have been a human pathogen throughout the entire history of our species. An estimated 30 ... |
| HIV Therapy Patent Landscape 2009 |
|
| Table of Contents Published: 2009/10 Published by: France Innovation Scientifique et Transfert (FIST SA) |
| The Human Immunodeficiency Virus (HIV) is a double-stranded RNA virus from the Retroviridae family. Discovered in 1983, HIV is responsible for the Acquired Immune Deficiency Syndrome (AIDS). Its mechanisms of action and transmission were described in the ... |
| Stroke: Treatments and Prescribing Practices - A Global Survey 2009 |
|
| Table of Contents Published: 2009/10 Published by: BioPharm Reports (Technology and Markets Ltd) |
| This report presents the findings of a global survey on current treatments and prescribing practices for Ischaemic Stroke, Haemorrhagic Stroke and Transient Ischaemic Attack (TIA). These findings were made following the participation of more than 230 clin ... |
| Immunotherapies and Vaccines for Nontraditional Indications |
|
| Table of Contents Published: 2009/10 Published by: Insight Pharma Reports |
| This report: Covers a wide range of conditions for which immunotherapies may be effective, including Alzheimer' s disease, addiction, other neurological indications, cardiovascular diseases, hematological disorders, ophthalmic diseases, bone metabolism di ... |
| Orphan Drug Strategies |
|
| Table of Contents Published: 2009/10 Published by: Datamonitor |
| With the pharmaceutical industry reducing its focus on the primary care blockbuster model, Big Pharma is now looking towards the development and commercialization of more niche, high value, often biologic therapies, for the treatment of smaller patient po ... |
| Pipeline Insight: HIV - The Age of Convenience |
|
| Table of Contents Published: 2009/10 Published by: Datamonitor |
| Three new partnerships are reshaping the competitive environment in HIV. Most notably, Tibotec/Johnson & Johnson is linking up with Gilead to combine their Phase III drug rilpivirine with Truvada to create a new gold standard fixed dose combination for tr ... |
| Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile |
|
| Table of Contents Published: 2009/10 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Chugai in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa ... |
| Allergan Inc.: PharmaVitae Profile |
|
| Table of Contents Published: 2009/10 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Allergan in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales fore ... |
| Alternative Medicine |
|
| Table of Contents Published: 2009/10 Published by: Global Industry Analysts, Inc. |
| The global outlook series on Alternative Medicine provides anecdotes, market briefs, and concise summaries of research findings. The report highlights the primary growth drivers, market challenges, and reviews global and regional trends across various seg ... |
| Oxygen Therapy |
|
| Table of Contents Published: 2009/10 Published by: Global Industry Analysts, Inc. |
| The global outlook series on Oxygen Therapy provides statistical anecdotes, market briefs, and concise summaries of research findings. The report offers an aerial view of the global oxygen therapy industry, identifies major short to medium term market cha ... |
| Drug Delivery Partnering Agreements in Pharma and Biotech |
|
| Table of Contents Published: 2009/10 Published by: CurrentPartnering, a division of Wildwood Ventures Limited |
| The Drug Delivery Partnering Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the drug delivery partnering agreements entered into by the worlds leading healthcare companies. ... |
| Infectious Diseases Drugs Markets |
|
| Table of Contents Published: 2009/10 Published by: Trimark Publications |
| According to the World Health Organization (WHO), six infectious diseases--pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS--account for half of all premature deaths worldwide, killing mostly children and young adults. ... |
| Disposable Syringe Markets |
|
| Table of Contents Published: 2009/10 Published by: Trimark Publications |
| This TriMark Publications report examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor disease and to administer medications. This analysis is intended to provid ... |
|
|
|
View Cart
Top